Fang JM - Search Results

1

T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.

Chou AH, Chen YL, Chiu CC, Yuan SJ, Weng YH, Yeh TH, Lin YL, Fang JM, Wang HL. Chou AH, et al. Among authors: fang jm. Neuropharmacology. 2015 Dec;99:308-17. doi: 10.1016/j.neuropharm.2015.08.009. Epub 2015 Aug 6. Neuropharmacology. 2015. PMID: 26254860

2

Neuroprotective principles from Gastrodia elata.

Huang NK, Chern Y, Fang JM, Lin CI, Chen WP, Lin YL. Huang NK, et al. Among authors: fang jm. J Nat Prod. 2007 Apr;70(4):571-4. doi: 10.1021/np0605182. Epub 2007 Mar 24. J Nat Prod. 2007. PMID: 17381154

3

Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotection.

Chen JB, Liu EM, Chern TR, Yang CW, Lin CI, Huang NK, Lin YL, Chern Y, Lin JH, Fang JM. Chen JB, et al. Among authors: fang jm. ChemMedChem. 2011 Aug 1;6(8):1390-400. doi: 10.1002/cmdc.201100126. Epub 2011 Jun 20. ChemMedChem. 2011. PMID: 21692183

4

A new drug design targeting the adenosinergic system for Huntington's disease.

Huang NK, Lin JH, Lin JT, Lin CI, Liu EM, Lin CJ, Chen WP, Shen YC, Chen HM, Chen JB, Lai HL, Yang CW, Chiang MC, Wu YS, Chang C, Chen JF, Fang JM, Lin YL, Chern Y. Huang NK, et al. Among authors: fang jm. PLoS One. 2011;6(6):e20934. doi: 10.1371/journal.pone.0020934. Epub 2011 Jun 21. PLoS One. 2011. PMID: 21713039 Free PMC article.

5

Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis.

Liu YJ, Ju TC, Chen HM, Jang YS, Lee LM, Lai HL, Tai HC, Fang JM, Lin YL, Tu PH, Chern Y. Liu YJ, et al. Among authors: fang jm. Hum Mol Genet. 2015 Feb 1;24(3):787-801. doi: 10.1093/hmg/ddu497. Epub 2014 Sep 25. Hum Mol Genet. 2015. PMID: 25256353

6

A dual inhibitor targeting HMG-CoA reductase and histone deacetylase mitigates neurite degeneration in LRRK2-G2019S parkinsonism.

Lin CH, Lin HY, Fang JM, Chen CC. Lin CH, et al. Among authors: fang jm. Aging (Albany NY). 2020 Nov 24;12(24):25581-25598. doi: 10.18632/aging.104165. Epub 2020 Nov 24. Aging (Albany NY). 2020. PMID: 33231564 Free PMC article.

7

From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?

Cheng CK, Tsai CH, Shie JJ, Fang JM. Cheng CK, et al. Among authors: fang jm. Future Med Chem. 2014 May;6(7):757-74. doi: 10.4155/fmc.14.30. Future Med Chem. 2014. PMID: 24941871 Review.

8

Synthesis and bioactivity of β-(1→4)-linked oligomannoses and partially acetylated derivatives.

Ohara K, Lin CC, Yang PJ, Hung WT, Yang WB, Cheng TJ, Fang JM, Wong CH. Ohara K, et al. Among authors: fang jm. J Org Chem. 2013 Jul 5;78(13):6390-411. doi: 10.1021/jo4005266. Epub 2013 Jun 18. J Org Chem. 2013. PMID: 23745711

9

Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.

Hong BT, Chen CL, Fang JM, Tsai KC, Wang SY, Huang WI, Cheng YE, Wong CH. Hong BT, et al. Among authors: fang jm. Bioorg Med Chem. 2014 Dec 1;22(23):6647-6654. doi: 10.1016/j.bmc.2014.10.005. Bioorg Med Chem. 2014. PMID: 25456388

10

Peramivir conjugates as orally available agents against influenza H275Y mutant.

Wang PC, Chiu DC, Jan JT, Huang WI, Tseng YC, Li TT, Cheng TJ, Tsai KC, Fang JM. Wang PC, et al. Among authors: fang jm. Eur J Med Chem. 2018 Feb 10;145:224-234. doi: 10.1016/j.ejmech.2017.12.072. Epub 2017 Dec 24. Eur J Med Chem. 2018. PMID: 29324342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters